CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

vitOrganArzneimittel GmbH has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Homeopathic Products Suppliers in Europe - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Jürgen Leist, Managing Director.

vitOrganArzneimittel GmbH
Restoring Balance to Disrupted Processes in Diseases

vitOrganArzneimittel GmbH

Jürgen Leist, vitOrganArzneimittel GmbH | Life Science Review | Top Homeopathic Products Suppliers in EuropeJürgen Leist, Managing Director
As vitOrgan Arzneimittel GmbH celebrates its 70th anniversary in 2024, it remains steadfast in upholding the foundational trifecta envisioned by its founder since inception— commitment to pioneering research, steadfast faith, and the courage to translate vision into action.

Operating still as an independent family business today, vitOrgan focuses on top quality in the production and manufacture of its unique preparations. The company has attained unparalleled quality in its products through an innovative production process, positioning itself as a pioneering force in international preparation based on organ extracts.

“For us, 'Made in Germany' is more than just a brand, it's a commitment consistently upheld. The highest standard of product quality contributes significantly to the therapeutic success of our unique Biomolecular vitOrgan Therapy (BvT),” says Jürgen Leist, the managing director of vitOrgan. “Our therapists are seeing very good therapeutic successes, especially in indications that cannot yet be treated satisfactorily or at all by conventional medicine. I am therefore very confident that we will be able to further expand our position in the pharmaceutical market and turn vitOrgan into an internationally renowned naturopathy company.”

Biomolecular vitOrgan Therapy (BvT) harnesses the natural regulatory and metabolically active cell plasma substances to restore balance to disrupted processes in diseases. This facilitates a causal approach to patient treatment. Unlike traditional methods using fresh cells (first generation organ preparations) or complete cell content (second generation organ preparations), vitOrgan exclusively utilizes specific cell plasma components.

These components contain the essential factors for optimizing organ cell function and regeneration. Extracted from healthy and young cells of animal origin, these cytoplasmic cell factors are obtained through a uniquely modern and validated manufacturing process.

vitOrgan Arzneimittel GmbH supplies the organism with vital information sourced from young and healthy cells of animal origin. These cells furnish old and diseased cells with the essential impulses for regeneration and optimal function. Consequently, the diseased organism can break free from its degenerative "passivity" and actively participate in its own recovery process. This approach enables the reactivation of the cells' maximum metabolic capacity. The outcome is not only enhanced performance but also an extension of the cells' lifespan up to their genetic limit.

For us, 'Made in Germany' is more than just a brand, it's a commitment consistently upheld. The highest standard of product quality contributes significantly to the therapeutic success of our unique biomolecular vitOrgan therapy


The company’s medicinal products, dietary supplements, cosmetics, and Bach flower organ complexes are all manufactured in Germany, adhering strictly to the highest quality standards of pharmaceutical production. They are governed by the principles of "Good Manufacturing Practice" (GMP).

Quality assurance is paramount to vitOrgan. Every process that could impact the quality of a medicinal product undergoes rigorous scrutiny. This is achieved through a comprehensive SOP system, skilled personnel, and state-of-the-art equipment.

The exceptional quality of vitOrgan Arzneimittel GmbH’s medicinal products is evident from the moment raw materials are released. Its exclusive use of certified and tested organs of animal origin, combined with a unique, validated manufacturing process in accordance with GMP standards, ensures drug safety as per the provisions of the German Medicines Act (AMG) and the current Homeopathic Pharmacopoeia (HAB).

Despite its extensive experience and qualifications, the company remains committed to continuous improvement. Recently, vitOrgan Arzneimittel GmbH was adjudged with the Employer of the Future award after passing a rigorous two-stage assessment process. The prestigious accolade enables the company to highlight its qualities, fostering orientation and trust among applicants, and enhancing its competitiveness for top talent. As vitOrgan Arzneimittel GmbH looks to the future, this recognition underscores its capability to thrive and grow, ensuring continued success in an increasingly competitive landscape.

Top 10 Homeopathic Products Suppliers in Europe - 2024
Current Issue

Company : vitOrganArzneimittel GmbH

Management
Jürgen Leist, Managing Director

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/vitorganarzneimittel-gmbh